PP
BOLD

Paloma Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

Paloma Partners’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-55,813
Closed -$3.34M – 2398
2019
Q4 		$3.34M Buy
+55,813
New +$2.09M 0.05% 386

Paloma Partners's BOLD Position: Q1 2020 in Review

Paloma Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 55,813 shares — an estimated $3.34M sold.

Paloma Partners first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $3.34M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Paloma Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Paloma Partners sold 55,813 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3.34M.
  • Paloma Partners first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Paloma Partners's Audentes Therapeutics, Inc position peaked at $3.34M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.